الصفحة الرئيسية>>Signaling Pathways>> Others>>Aspartyl-alanyl-diketopiperazine

Aspartyl-alanyl-diketopiperazine (Synonyms: DA-DKP)

رقم الكتالوجGC35410

Aspartyl-alanyl-diketopiperazine (DA-DKP) هو جزيء مناعي ناتج عن الانقسام والدوران من الطرف N للألبومين البشري ويمكن أن يعدل الاستجابة المناعية الالتهابية من خلال المسار الجزيئي المتورط في الحساسية اللمفاوية التائية

Products are for research use only. Not for human use. We do not sell to patients.

Aspartyl-alanyl-diketopiperazine التركيب الكيميائي

Cas No.: 110954-19-3

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
357٫00
متوفر
5mg
324٫00
متوفر
10mg
510٫00
متوفر
50mg
1530٫00
متوفر
100mg
2457٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Aspartyl-alanyl-diketopiperazine (DA-DKP) is an immunomodulatory molecule generated by cleavage and cyclization from the N-terminus of human albumin and can modulate the inflammatory immune response through a molecular pathway implicated in T- lymphocyte anergy[1][2].

[1]. Bar-Or D, et al. Dipeptidyl peptidase IV activity in commercial solutions of human serum albumin. Anal Biochem. 2013 Oct 1;441(1):13-7. [2]. Shimonkevitz R, et al. A diketopiperazine fragment of human serum albumin modulates T-lymphocyte cytokine production through rap1. J Trauma. 2008 Jan;64(1):35-41.

مراجعات

Review for Aspartyl-alanyl-diketopiperazine

Average Rating: 5 ★★★★★ (Based on Reviews and 7 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Aspartyl-alanyl-diketopiperazine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.